前收市價 | 147.56 |
開市 | 147.94 |
買盤 | 144.04 x 100 |
賣出價 | 144.38 x 200 |
今日波幅 | 143.31 - 148.12 |
52 週波幅 | 55.25 - 173.25 |
成交量 | |
平均成交量 | 1,898,475 |
市值 | 13.634B |
Beta 值 (5 年,每月) | 0.88 |
市盈率 (最近 12 個月) | 335.44 |
每股盈利 (最近 12 個月) | 0.43 |
業績公佈日 | 2024年7月31日 - 2024年8月05日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 196.69 |
A trio of peculiar picks.
The average of price targets set by Wall Street analysts indicates a potential upside of 38% in Sarepta Therapeutics (SRPT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Sarepta Therapeutics (SRPT) have what it takes to be a top stock pick for momentum investors? Let's find out.